News

Patients with myasthenia gravis who have vision problems should be screened for possible autoimmune retinopathy.

Mesenchymal stem cells can calm immune system attacks and slow the muscle wasting seen in MG, potentially improving strength and endurance.

Platelets are more than blood-clotting cells; they actively influence the immune system in untreated myasthenia gravis, worsening symptoms.

Genetic testing may show that some patients diagnosed with seronegative MG actually have congenital myasthenic syndrome (CMS).

The secretion of a protein known as BAFF by white blood cells contributes to the exacerbation of myasthenia gravis.

CNP-106 works by downregulating overactive immune responses in patients with generalized MG caused by anti-AChR antibodies.

A recent study identified adverse events attributed to efgartigimod alfa use that are not currently listed in the drug’s manual.

C-reactive protein was significantly associated with fatigue in MG.

Patients with myasthenia gravis faced significant health-related anxiety during COVID-19, especially due to infection and treatment risks.

Patients with AOMG have more bulbar problems, lower prevalence of thymoma, less aggressive treatment approaches and higher mortality rates.